Sectors
Share
The concern about proposed US tariffs on the pharmaceutical industry
Tariff uncertainty and budget cuts will hamper US pharma's innovative capacity
Healthcare should see decent growth over the coming year, but rising vacancies could throw a spanner in the works
Tariffs won't bring the manufacturing of generic pharmaceuticals back to the US, but there are alternatives
